Owner Isis Pharmaceuticals, Inc. Antisense Therapeutics Limited

Inventors Tachas, George; Belyea, Christopher; Dobie, Kenneth; Jain, Ravi; Heffernan, Mark

Agent FB Rice

Pub. Number AU-B-2004217508

PCT Pub. Number WO2004/078922

Priority 60/490,230 25.07.03 US; 60/451,455 28.02.03 US; 10/789,526 26.02.04 US

Filing date 27 February 2004

Wipo publication date 16 September 2004

Acceptance publication date 16 September 2010

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids